Cardinal Health Inc

CAH: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
mZQLOCK|<&#XvLOCK|%>kw#l!

Cardinal Health: Investor Day Highlights Solid Distribution Trend and Strong Long-Term Targets

Business Strategy and Outlook

Cardinal Health is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $200 billion in annual US drug distribution sales in fiscal 2024, the firm supplies roughly one fourth of the overall market. Its two close competitors are Cencora and McKesson, and together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Sponsor Center